Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV Iron vs Oral Iron for Chemotherapy-Induced Anemia in Colon Cancer
NCT05299411Phase 2Not yet recruiting
- Sponsor
- Korea University Guro Hospital
- Start
- Apr 2023
- Primary completion
- Mar 2025
- Modality
- Inorganic Nanoparticles, Small Molecules
01
Overview
Phase 2, randomised, open-label trial of ferric derisomaltose (2 arms), sponsored by Korea University Guro Hospital. Primary endpoint: Serum Hemoglobin level. Planned start Apr 2023; status: not yet recruiting.
02
Drugs
ferric derisomaltose
Beyond the preview
Go deeper on NCT05299411.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05299411.